Percutaneous radiofrequency ablation of renal cell carcinoma
- PMID: 15756553
- DOI: 10.1007/s00330-005-2651-y
Percutaneous radiofrequency ablation of renal cell carcinoma
Abstract
Conventional curative therapy for renal cell carcinoma has been open nephrectomy. However, several less invasive and/or nephron-sparing procedures have been developed as alternatives in selected patients. The newest of these therapeutic modalities involves percutaneous image-guided ablation with straight or expandable needle applicators that deposit energy. Radiofrequency ablation is the modality for which there is the largest reported experience with percutaneous application, and involves the use of electrical current to generate frictional heating of tissue. Animal studies confirm the ability of radiofrequency ablation to cause regions of necrosis within normal kidney and in VX2 tumors. Clinically, radiofrequency ablation of small renal cell carcinoma is increasingly being performed in selected patients who are not ideal surgical candidates. Results are excellent for small exophytic tumors, but successful treatment is less likely as tumor size increases or the location becomes more central. Complete treatment of most tumors requires one or more overlapping ablations with the needle electrodes positioned so as to cause necrosis in the entire volume of tumor. The number of overlapping ablations and the position of the needle electrodes vary based on tumor size and geometry. For very large tumors, pre-ablation catheter embolization may enhance the results of ablation by decreasing blood flow and perfusion mediated cooling. Following ablation, imaging with CT or MR is performed to assess the result and to diagnose any residual tumor so that it can be treated. Because the tumor remains in situ, imaging follow-up continues indefinitely. The complication rate of radiofrequency ablation is favorable when compared to surgical techniques. Long-term survival data are not yet available.
Similar articles
-
Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors.AJR Am J Roentgenol. 2005 Jul;185(1):64-71. doi: 10.2214/ajr.185.1.01850064. AJR Am J Roentgenol. 2005. PMID: 15972400
-
Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.Eur J Radiol. 2006 Aug;59(2):183-9. doi: 10.1016/j.ejrad.2006.04.012. Epub 2006 May 24. Eur J Radiol. 2006. PMID: 16725292 Clinical Trial.
-
Imaging-guided radiofrequency ablation of solid renal tumors.AJR Am J Roentgenol. 2003 Jun;180(6):1509-13. doi: 10.2214/ajr.180.6.1801509. AJR Am J Roentgenol. 2003. PMID: 12760910
-
[Percutaneous radiofrequency ablation of renal cell cancer].Radiologe. 2004 Apr;44(4):358-63. doi: 10.1007/s00117-004-1035-7. Radiologe. 2004. PMID: 15048557 Review. German.
-
Image-guided ablation of renal cell carcinoma.Magn Reson Imaging Clin N Am. 2004 Aug;12(3):429-47, vi. doi: 10.1016/j.mric.2004.03.003. Magn Reson Imaging Clin N Am. 2004. PMID: 15271364 Review.
Cited by
-
Ablative therapies for renal tumors.Ther Adv Urol. 2010 Apr;2(2):51-68. doi: 10.1177/1756287210366708. Ther Adv Urol. 2010. PMID: 21789083 Free PMC article.
-
[Energy ablative therapy of renal tumours].Urologe A. 2007 May;46(5):485-6, 488-90, 492-5. doi: 10.1007/s00120-007-1337-2. Urologe A. 2007. PMID: 17453171 Review. German.
-
Current oncologic applications of radiofrequency ablation therapies.World J Gastrointest Oncol. 2013 Apr 15;5(4):71-80. doi: 10.4251/wjgo.v5.i4.71. World J Gastrointest Oncol. 2013. PMID: 23671734 Free PMC article.
-
Renal Cell Carcinoma Ablation: Preprocedural, Intraprocedural, and Postprocedural Imaging.Radiol Imaging Cancer. 2019 Nov 29;1(2):e190002. doi: 10.1148/rycan.2019190002. eCollection 2019 Nov. Radiol Imaging Cancer. 2019. PMID: 33778679 Free PMC article. Review.
-
Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term results.Eur Radiol. 2013 Jul;23(7):1933-9. doi: 10.1007/s00330-013-2802-5. Epub 2013 Mar 9. Eur Radiol. 2013. PMID: 23475163
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical